Thomas Ciulla

Thomas Ciulla

Company: Clearside Biomedical

Job title: Chief Medical Officer & Chief Development Officer


Overviewing Suprachoroidal Delivery & its Role in Treating Retinal Vascular Diseases 4:15 pm

Weighing the benefits of suprachoroidal delivery therapeutics for improved efficacy and durability for reduced patient burden Outlining the current technology and new developments Looking to the future of retinal vascular drug delivery and the place of suprachoroidal deliveryRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.